Patients with advanced pancreatic cancer, one of the most deadly malignancies, may live a little longer when treated with two therapeutic vaccines, new research suggests. In a study of 90 patients, this combination approach -- GVAX ...
Tags: a
Patients with advanced pancreatic cancer, one of the most deadly malignancies, may live a little longer when treated with two therapeutic vaccines, new research suggests. In a study of 90 patients, this combination approach -- GVAX ...
US Department of Defense has granted a Congressionally Directed Medical Research Programs (CDMRP) grant to Aduro BioTech to complete the preclinical development of a new therapeutic cancer vaccine for prostate cancer. Aduro's cancer ...
Tags: Aduro, cancer vaccine platform, IND